CLS Americas Announces Agreement with AVANT Concierge Urology to Treat Prostate Cancer Patients with TRANBERG™ Thermal Therapy System
19. April 2023 02:50 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and ORLANDO, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for...
CLS Americas and HALO Precision Diagnostics Announce 25 Patient Post-Market Study to Evaluate CLS’s TRANBERG Thermal Therapy System
08. Februar 2023 12:25 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and INDIAN WELLS, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems...
CLS Americas Exhibits TRANBERG Fusion-Guided Focal Laser Ablation Solution at Western Section AUA Meeting
01. November 2022 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
KAUAI, Hawaii, Nov. 01, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced it will exhibit its TRANBERG™ Thermal Therapy System at the 98th...
CLS Americas & Focalyx Present Integrated Fusion-Guided Focal Laser Ablation Solution at FOCAL 2022 Conference
23. September 2022 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LOS ANGELES, Sept. 23, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, and Focalyx Technologies, developer of image-guided fusion target devices, today...
CLS Americas Debuts Office-Based, Fusion-Guided TRANBERG Focal Laser Ablation System at AUA 2022 Conference
12. Mai 2022 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced it will debut its Office-Based, MR/US Fusion-Guided, TRANBERG®...
CLS Americas and URN Announce First Patient Treated in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”
20. April 2022 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and MIAMI, April 20, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced the first patient has been safely treated in its recently...